Information Provided By:
Fly News Breaks for January 11, 2017
IART, DSCI
Jan 11, 2017 | 17:51 EDT
Piper Jaffray analyst Matt O'Brien said he viewed the Integra LifeSciences (IART) acquisition of Derma Sciences (DSCI) favorably due to it accelerating an amniotic product offering and adding 50 direct sales reps. Piper has an Overweight rating on Integra.
News For IART;DSCI From the Last 2 Days
There are no results for your query IART;DSCI